NIH Indian Association Presents
Mini-symposium: Current Trends in Clinical Research and Drug Development in India
Date and Time: May 7, 2006, 5:30 8:30 pm
Venue: BioReliance Headquarters
Building 1, Room 1105
14920 Broschart Road, Rockville, MD 20850
Agenda:
5:30 5:45 pm Introduction
5:45 6:15 pm Preclinical and Clinical Research in India with Emphasis on Eye Diseases (audio)
Padmasri Prof. Balasubramaniam, Ph.D.
Director of Research, L V Prasad Eye Institute, Hyderabad, India
6:15 6:45 pm Drug Discovery Research in India and the Institute of Life Sciences Initiative (audio)
Dr. Venkateswarulu, Ph.D., Director, Institute of Life Sciences ((Formerly President - Dr. Reddys Research Foundation, Dr. Reddys Labs , Hyderabad, India)
6:45 8:30 pm Biotech Product Development: Perspectives from professionals in the industry and academia- A Round Table Discussion and Open-Mike session (A panel of experts from Biotech industry, NIH, FDA and other organizations presented their thoughts and participated in discussion with the audience)
Moderators: Mukesh Kumar, Ph.D. and Ruchika Nijhara, Ph.D.
Discussions:
- Global collaborations developing interactions between the academia and industry, international collaborations - Dr. Shiv Srivastav, Ph. D, Scientific Director, Ctre for Prostate Disease Rsch, USUHS, Bethesda.
- Outsourcing the current status of biotech outsourcing both within the country and across the borders, development of human resource and technology transfer for Pharmaceutical and its support industry in India. - Dr. Mahadev Murthy, NCRR, NIH, Bethesda with comments from Dr. Venkateswarlu.
- Drug discovery/development programs preclinical research, regulatory processes Dr. Rama Gudi, Bioreliance, Invitrogen, Rockville, MD.
- Bioinformatics Role of bioinformatics in biotechnology and future projections, Dr. Shankar Rachakonda, CEO, SCI Group, Lanham, MD.
- Mentoring Importance of finding a mentor for professional development, how to approach people for mentoring, the code of conduct, Dr. Durga Paruchuri, President, DNA Lynx, Marketing Manager, Johnson & Johnson
- Entrepreneurship developing business opportunities, Dr. K Paul Thadikonda, CEO, EMINENT Services, Frederick, MD
Click to listen to the audio of the entire roundtable discussion
For details, contact Dr. Murali Krishna Cherukuri (murali@helix.nih.gov, 301-496-7511), Dr. Mukesh Kumar (mukeshmaryland@yahoo.com, 301-221-3578) and Dr. Krishna Balakrishnan (balki@nih.gov).
Bios of the chief guests:
Prof. D. Balasubramanian is an outstanding academician and researcher. He is the recipient of "PadmaShri, one of the top civilian national honors, by the President of India, and Chevalier de l'Ordre National de Merite, by the President of France. He pursued his doctoral studies at Columbia University, New York and postdoctoral research from University of Minnesota Medical School. His primary areas of research include molecular and cellular approaches to understand and treat diseases of the eye. He has published 145 research papers and 2 books. He is an NIH alumnus (1979, 1988) and was instrumental in the recent formalization of the US-India Vision research agreement signed by Dr Zerhouni, Director, NIH and Dr Ganguly, Director General, ICMR.
Dr. A. Venkateswarlu is an eminent Indian scientist with extensive experience in research and management and significant achievements in Pharma industry. Dr. Venkateswarlu has an outstanding track record in R & D management. He has contributed to both academic and industrial research with 30 research papers, 38 patent applications and 8 issued patents. A Fulbright scholar, he pursued his doctoral studies in organic chemistry at Wayne State University and University of Pennsylvania, and pursued post-doctoral research at Harvard University. His paper with E. J. Corey describing the discovery and development of TBDMS Protecting Group continues to be the most cited paper in organic chemistry even after 34 years of its publication.